XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 CAS 129186-29-4

Purity 97%+In StockPharmaceutical Standards
CAS No.129186-29-4
Molecular FormulaC17H15BrN4O2
Molecular Weight387.23 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 CAS 129186-29-4 chemical structure

Description

Compared with other compounds in its class, the molecular weight of 387.23 g/mol gives XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 (CAS 129186-29-4), a certified reference material (molecular formula C17H15BrN4O2, MW 387.23 g/mol) for analytical method development and quality control.

Structurally, XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 (C17H15BrN4O2) contains a steroid core, an amide group, a hydroxyl group, an ether linkage, bromine substitution. The molecule exhibits a degree of unsaturation (DBE) of 12.0, corresponding to approximately 12 ring(s) or double-bond equivalent(s). With a molecular weight of 387.23 g/mol, it falls into the moderately-high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.

CATO manufactures XMJ87I93Y9 129186-29-4 Gidazepam (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one UNII-XMJ87I93Y9 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC17H15BrN4O2
Molecular Weight387.23 g/mol
AppearancePale yellow to yellow crystalline powder. (slight halide-like odor)
Purity97%+
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)12.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1993
Halogen ContentBr-containing
Nitrogen Atoms4

Recommended Standards

Why CATO?